Global Biostimulators Injection Services Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biostimulators Injection Services Market Insights, Forecast to 2034
Biostimulators are a breakthrough in aesthetic medicine, which naturally encourage the production of collagen. Elastin and collagen are the ‘scaffolding’ of the face and as they diminish with age, we lose structure and elasticity. Biocompatible synthetic stimulants are injected beneath the surface of the skin and serve to restore volume, thus rejuvenating and improving skin quality and appearance. The injectables function by stimulating the production of the body’s natural fibroblast - cells which create collagen and elastin. Once the cycle is complete and the collagen production has occurred (along with all components of the extracellular matrix) the biodegradable synthetic substances are then naturally absorbed by the body.
Market Analysis and InsightsGlobal Biostimulators Injection Services Market
Global Biostimulators Injection Services market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biostimulators Injection Services industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to the data of the International Society of Aesthetic Plastic Surgery (ISAPS), in 2021, there was approximately 12.84 million surgical and plastic treatments worldwide, an increase of 18.5% year-on-year; the number of non-surgical plastic surgery treatments was 18.6 million, a year-on-year increase of 19.9%. Among them, three countries holding the largest numbers of treatment courses are the United States, Brazil and Japan, with 7.35 million, 2.72 million and 1.75 million respectively. From the perspective of the number of plastic surgeons, the United States, Brazil and China have the largest number of doctors, accounting for 17%, 13.6% and 6.8% of the global total respectively. According to ASAPS data, the overall size of the US medical aesthetics market in 2020 was US$9.308 billion, a year-on-year increase of 14.63%. Among them, the market share of surgical procedures was US$6.177 billion, accounting for 66.36%; the market size of non-surgical procedures was US$3.131 billion, accounting for 33.64%. The US medical aesthetics market is generally stable, and the proportion of the non-surgical medical aesthetics market continues to rise.
Report Covers
This report presents an overview of global Biostimulators Injection Services market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biostimulators Injection Services market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
San Diego Eyelid Specialists
Manor Medical Aesthetics
Skin Essentials
Dr K's Clinic
Dr Bela Clinic
INJEX CLINICS
Ozderm Clinic
The Manse Clinic
Eltham Cosmetic Clinic
The Laser and Skin Clinic
Ocean Clinic
Face To Face Medical
Elite Medical Centre
Body Dezign House
BLANC SKIN
Radiance Skin and Laser
Segment by Type
Anti-Aging
Repair Scars
Others
Cheek
Jaw
Temple
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biostimulators Injection Services introduction, etc. Biostimulators Injection Services Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Biostimulators Injection Services
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Biostimulators Injection Services Market
Global Biostimulators Injection Services market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biostimulators Injection Services industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to the data of the International Society of Aesthetic Plastic Surgery (ISAPS), in 2021, there was approximately 12.84 million surgical and plastic treatments worldwide, an increase of 18.5% year-on-year; the number of non-surgical plastic surgery treatments was 18.6 million, a year-on-year increase of 19.9%. Among them, three countries holding the largest numbers of treatment courses are the United States, Brazil and Japan, with 7.35 million, 2.72 million and 1.75 million respectively. From the perspective of the number of plastic surgeons, the United States, Brazil and China have the largest number of doctors, accounting for 17%, 13.6% and 6.8% of the global total respectively. According to ASAPS data, the overall size of the US medical aesthetics market in 2020 was US$9.308 billion, a year-on-year increase of 14.63%. Among them, the market share of surgical procedures was US$6.177 billion, accounting for 66.36%; the market size of non-surgical procedures was US$3.131 billion, accounting for 33.64%. The US medical aesthetics market is generally stable, and the proportion of the non-surgical medical aesthetics market continues to rise.
Report Covers
This report presents an overview of global Biostimulators Injection Services market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biostimulators Injection Services market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
San Diego Eyelid Specialists
Manor Medical Aesthetics
Skin Essentials
Dr K's Clinic
Dr Bela Clinic
INJEX CLINICS
Ozderm Clinic
The Manse Clinic
Eltham Cosmetic Clinic
The Laser and Skin Clinic
Ocean Clinic
Face To Face Medical
Elite Medical Centre
Body Dezign House
BLANC SKIN
Radiance Skin and Laser
Segment by Type
Anti-Aging
Repair Scars
Others
Segment by Application
Cheek
Jaw
Temple
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biostimulators Injection Services introduction, etc. Biostimulators Injection Services Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Biostimulators Injection Services
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports